Pharmacists in Hot Springs, South Dakota


28 Pharmacists found in Hot Springs
male pharmacist

Dr. Peter J Kearns, PHARMD


Pharmacist
500 N 5th St, Hot Springs, SD 57747
605-745-2000     605-745-2839

male pharmacist

Dr. Robert Wayne Puffer, RPH


Pharmacist
2233 Lincoln Ave, Hot Springs, SD 57747
605-745-4819    

male pharmacist

Dr. Robert Lacharite, PHARMD


Pharmacist
500 N 5th St, Attn Pharmacy, Hot Springs, SD 57747
605-745-2000    



male pharmacist

Roland Theodore Wick


Pharmacist
2701 Highway 18 W, Hot Springs, SD 57747
605-745-4681     605-745-4813

female pharmacist

Dr. Sara Jean Carlson, PHARM D


Pharmacist
500 N 5th St, Hot Springs, SD 57747
605-745-2000    

female pharmacist

Sarah Opitz, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
500 N 5th St, Hot Springs, SD 57747
605-745-2000    

male pharmacist

Dr. Shawn Michael Dalton, PHARM.D.


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
500 N 5th St, Hot Springs, SD 57747
605-754-2000    

female pharmacist

Dr. Shelly L Gardner, PHARMD


Pharmacist
1201 Highway 71 S, Hot Springs, SD 57747
605-745-8910     605-745-8910

female pharmacist

Suzanne Beth Kopp, PHARMD


Pharmacist
505 N. River St., Suite 2&3, Hot Springs, SD 57747
605-745-3320     605-745-3324

female pharmacist

Tara J Butler, R,PH


Pharmacist
500 N 5th St, Hot Springs, SD 57747
605-745-2100    

female pharmacist

Dr. Tiffany Halling Jastorff Gillies, PHARMD


Pharmacist
500 N 5th St, Pharm, Hot Springs, SD 57747
605-745-2000    

female pharmacist

Yin Shi, PHARMD


Pharmacist
500 N 5th St, Hot Springs, SD 57747
347-241-0300    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.